Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Current Assets (2023 - 2025)

Upstream Bio has reported Current Assets over the past 3 years, most recently at $351.8 million for Q4 2025.

  • Quarterly results put Current Assets at $351.8 million for Q4 2025, down 26.58% from a year ago — trailing twelve months through Dec 2025 was $351.8 million (down 26.58% YoY), and the annual figure for FY2025 was $351.8 million, down 26.58%.
  • Current Assets for Q4 2025 was $351.8 million at Upstream Bio, down from $389.0 million in the prior quarter.
  • Over the last five years, Current Assets for UPB hit a ceiling of $479.2 million in Q4 2024 and a floor of $117.0 million in Q4 2023.
  • Median Current Assets over the past 3 years was $389.0 million (2025), compared with a mean of $348.0 million.
  • Biggest five-year swings in Current Assets: soared 309.55% in 2024 and later decreased 26.58% in 2025.
  • Upstream Bio's Current Assets stood at $117.0 million in 2023, then soared by 309.55% to $479.2 million in 2024, then fell by 26.58% to $351.8 million in 2025.
  • The last three reported values for Current Assets were $351.8 million (Q4 2025), $389.0 million (Q3 2025), and $418.3 million (Q2 2025) per Business Quant data.